ADVERTISEMENT

Sun Pharma

Sun Pharma Q2 net profit rises 28% to Rs 3,040 crore

Total income rose to Rs 13,645 crore in the second quarter compared to Rs 12,486 crore in the year-ago period.

28 October 2024, 10:29 IST

Sun Pharma Q2 net profit rises 28% to Rs 3,040 crore

Sun Pharma Q2 net profit rises 28% to Rs 3,040 crore

Sun Pharma Q2 net profit rises 28% to Rs 3,040 crore

28 October 2024, 10:29 IST

Sun Pharma inks licensing pact with Philogen for cancer medication

As per the agreement, Sun Pharma will have the exclusive worldwide rights to commercialise Fibromun, a speciality product of Philogen.

01 October 2024, 06:15 IST

Sun Pharma inks licensing pact with Philogen for cancer medication

Sun Pharma inks licensing pact with Philogen for cancer medication

Sun Pharma inks licensing pact with Philogen for cancer medication

01 October 2024, 06:15 IST

Did not manufacture drugs flagged in CDSCO report, say leading pharma companies

The Central Drugs Standard Control Organisation (CDSCO) has listed samples of more than 50 drugs, including paracetamol, Pan D, calcium and vitamin D3 supplements, and anti-diabetes pills, as 'not of standard quality' in its latest report.

26 September 2024, 16:02 IST

Did not manufacture drugs flagged in CDSCO report, say leading pharma companies

Did not manufacture drugs flagged in CDSCO report, say leading pharma companies

Did not manufacture drugs flagged in CDSCO report, say leading pharma companies

26 September 2024, 16:02 IST

Supreme Court dismisses Sun Pharma's plea on excess price of drug 'Roscilox'

'The intent and purpose thereof are to control the prices at which medicinal drug formulations are made available to the common man,' the bench observed.

15 July 2024, 14:40 IST

Supreme Court dismisses Sun Pharma's plea on excess price of drug 'Roscilox'

Supreme Court dismisses Sun Pharma's plea on excess price of drug 'Roscilox'

Supreme Court dismisses Sun Pharma's plea on excess price of drug 'Roscilox'

15 July 2024, 14:40 IST

Warning letter: USFDA pulls up Sun Pharma for manufacturing issues at Dadra facility

In a warning letter issued to company's Managing Director Dilip Shanghvi on June 18, the US health regulator stated it inspected the plant in the Union Territory of Dadra and Nagar Haveli and Daman and Diu from December 4-15, 2023.

03 July 2024, 14:11 IST

Warning letter: USFDA pulls up Sun Pharma for manufacturing issues at Dadra facility

Warning letter: USFDA pulls up Sun Pharma for manufacturing issues at Dadra facility

Warning letter: USFDA pulls up Sun Pharma for manufacturing issues at Dadra facility

03 July 2024, 14:11 IST

Sun Pharma posts net profit of Rs 2,654.58 cr in Jan-Mar quarter

Consolidated total revenue from operations in the fourth quarter was at Rs 11,982.9 crore in the quarter under review. It was at Rs 10,930.67 crore in the same quarter a year ago.

22 May 2024, 13:22 IST

Sun Pharma posts net profit of Rs 2,654.58 cr in Jan-Mar quarter

Sun Pharma posts net profit of Rs 2,654.58 cr in Jan-Mar quarter

Sun Pharma posts net profit of Rs 2,654.58 cr in Jan-Mar quarter

22 May 2024, 13:22 IST

Sun Pharma gets regulatory nod in Australia for acne treatment cream

Sun Pharma received the exclusive right to develop and commercialise Winlevi in the US, Japan, Australia, New Zealand, Brazil, Mexico, and Russia from Cosmo, it added.

19 March 2024, 05:11 IST

Sun Pharma gets regulatory nod in Australia for acne treatment cream

Sun Pharma gets regulatory nod in Australia for acne treatment cream

Sun Pharma gets regulatory nod in Australia for acne treatment cream

19 March 2024, 05:11 IST

Sun Pharma Q3 results: Net profit up 16.5% at Rs 2,523.8 crore

Consolidated total revenue from operations during the quarter under review stood at Rs 12,380.7 crore as compared to Rs 11,240.97 crore in the corresponding period a year ago.

31 January 2024, 11:49 IST

Sun Pharma Q3 net profit rises 16.5% to Rs 2,523.8 crore

Sun Pharma Q3 net profit rises 16.5% to Rs 2,523.8 crore

Sun Pharma Q3 results: Net profit up 16.5% at Rs 2,523.8 crore

31 January 2024, 11:49 IST

Sun Pharma to buy remaining stake in Israeli unit Taro for about $348 mn

The deal comes as a culmination to nearly 17 years of back and forth to gain full control of the US-listed generic drugmaker which does most of its business in the United States and Canada.

18 January 2024, 01:22 IST

Sun Pharma to buy remaining stake in Israeli unit Taro for about $348 mn

Sun Pharma to buy remaining stake in Israeli unit Taro for about $348 mn

Sun Pharma to buy remaining stake in Israeli unit Taro for about $348 mn

18 January 2024, 01:22 IST

Sun Pharma files new drug application with USFDA for investigational medicine to treat alopecia

In the new drug application, Sun Pharma has submitted the 8mg twice daily regimen of deuruxolitinib for US Food and Drug Administration (USFDA) review, the company said in a statement.

06 October 2023, 08:52 IST

Sun Pharma files new drug application with USFDA for investigational medicine to treat alopecia

Sun Pharma files new drug application with USFDA for investigational medicine to treat alopecia

Sun Pharma files new drug application with USFDA for investigational medicine to treat alopecia

06 October 2023, 08:52 IST